Recombinant Vaccines Research Report 2024: Market Poised for Accelerated Growth, Set to Reach $34.18 Billion by 2034 from $10.14 Billion in 2023
31 janv. 2024 11h23 HE
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Recombinant Vaccines Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global...
Global Malaria Vaccine Market Set for Remarkable Growth in the Fight Against Malaria
31 oct. 2023 08h08 HE
|
Research and Markets
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Malaria Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ResearchAndMarkets.com's...
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Malaria Vaccine Patent Granted in Brazil, the 25th Patent Allowance for Programs in Infectious Disease, Cancer and Fibrosis
08 juin 2023 08h01 HE
|
Ocean Biomedical, Inc.
Patent for breakthrough approach to disrupting the malaria parasite’s life cycle adds to a growing global patent portfolio, with 25 patents issued and an additional 38 patents pending. ...
GeoVax and Leidos Expand Collaboration to Malaria Vaccines
04 mars 2019 09h00 HE
|
GeoVax, Inc.
Supported by Contract from U.S. Agency for International Development (USAID) ATLANTA, GA, March 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a...